Αρχική World News Nursing Professor Who Used Her Breast Cancer Diagnosis as a Teaching Tool...

Nursing Professor Who Used Her Breast Cancer Diagnosis as a Teaching Tool Passes Away

In 2015, Joyce Degennaro was diagnosed with stage IV breast cancer. The diagnosis was understandably distressing for the nursing professor, but she refused to allow the disease to keep her from being an awesome nurse and teacher.

“I had a CT scan, and the doctor came back and said, ‘You do have cancer. It looks like cancer has spread to your lymph system,” Joyce recalled.

She continued teaching at the University of Central Florida College of Nursing while she sought treatment and decided to use her lump as a teaching tool in her classes.

Photo: Facebook/UCF College of Nursing

“So in my labs, I said, ‘Alright everybody, come feel this,’” Joyce said. “So they (my students) felt it, and then I said, ‘Alright, let’s do a complete lymph exam.’ So they started back here, and they started, and they said, ‘Oh, Ms. D, you have one right here.”

Joyce’s treatment truly changed the way she taught. After she realized what it was like to be on the other side of the healthcare system, she began documenting her experience and teaching her students about how to be more compassionate and thoughtful nurses.

Photo: Facebook/UCF College of Nursing

“I always thought I gave really good care until I was on the other side of the stethoscope,” she said. “And I was like, I can be so much better. Just the little things, like an ice pack that I never thought of that could relieve pain for someone, or holding someone’s hand.”

Article continues below

Our Featured Programs

See how we’re making a difference for People, Pets, and the Planet and how you can get involved!

Photo: Facebook/UCF College of Nursing

“She posted these videos for all of us to watch,” said nursing student Megan Donnelly, “and just the way that she connects that, her journey, into teaching in a very personal way, it’s amazing. She probably doesn’t even know how many times me and my friends will text each other and talk about her and be like, ‘If she can do everything she’s doing, we can definitely do this.’ I don’t think she has any idea the impact she has on all of us.”

For years, Joyce fought her cancer and seemed to be winning. She even went into remission on a few occasions, although each time it was followed by a recurrence. She seemed to be doing better than expected, but then her students noticed another red flag.

Photo: Facebook/UCF College of Nursing

“She was absent from class one day,” Donnelly recalled. “Whenever she was late or absent, we’d all get super worried.”

Days later, Joyce posted on Facebook that her cancer had returned with a vengeance. It had spread farther than ever before.

Shortly after Thanksgiving, Joyce went into the hospital, where she later passed away from her disease. She was just 41 years old.

Photo: Facebook/UCF College of Nursing

“The biggest loss really is those that will never be able to be taught by her,” said UCF College of Nursing Clinical Coordinator Kate Dorminy. “Those of us who will have to continue on without her, because she played such a significant role.”

Joyce touched thousands of lives while working at UCF, and she will be dearly missed by all her students and colleagues, who continue to remember her as the woman who powered through a difficult time in her life to continue teaching because she knew how important it was.

Photo: Facebook/UCF College of Nursing

“I think 10, 20, 40 years down the line…I think we’re all going to be keeping her in mind even then,” said Dorminy. “I wish I could talk to her kids, because that’s what I think about the most. To just let them know, ‘Your mom changed the world.’”

Joyce’s students and colleagues wore pink in her memory the Wednesday following the announcement of her death. May this wonderful woman, mother, and educator rest in peace after her job well done.

Provide Mammograms

Support those fighting Breast Cancer at The Breast Cancer Site for free!

Whizzco Source


Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...


Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...


ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Breast Cancer Survivor Invents Warming Bra Insert to Combat Cold Feeling of Breast Implants

In 2013, Kristen Carbone, of Providence, Rhode Island, had a preventative mastectomy to help protect herself against breast cancer after her mother died of...

FDA Approves Daratumumab plus Hyaluronidase-fihj, Carfilzomib, and Dexamethasone for Relapsed or Refractory Multiple Myeloma

On 30 November 2021, the US Food and Drug Administration (FDA) approved daratumumab plus hyaluronidase-fihj (Darzalex Faspro, Janssen Biotech, Inc.) and carfilzomib (Kyprolis, Amgen,...

Thanks For Making This GivingTuesday Our Best One Yet!

We set ambitious goals for GivingTuesday, but they were driven by a time of great need. With your help, we hoped to provide food and...

Over 600 people in England set to benefit from innovative lung cancer treatment

<img width="620" height="348" src="https://34p2k13bwwzx12bgy13rwq8p-wpengine.netdna-ssl.com/wp-content/uploads/2021/05/lung_cell_cropped-hero.jpg" class="attachment-featuredImage size-featuredImage" alt="Lung cancer cell" loading="lazy" srcset="https://34p2k13bwwzx12bgy13rwq8p-wpengine.netdna-ssl.com/wp-content/uploads/2021/05/lung_cell_cropped-hero.jpg 620w, https://34p2k13bwwzx12bgy13rwq8p-wpengine.netdna-ssl.com/wp-content/uploads/2021/05/lung_cell_cropped-hero-300x168.jpg 300w, https://34p2k13bwwzx12bgy13rwq8p-wpengine.netdna-ssl.com/wp-content/uploads/2021/05/lung_cell_cropped-hero-220x123.jpg 220w, https://34p2k13bwwzx12bgy13rwq8p-wpengine.netdna-ssl.com/wp-content/uploads/2021/05/lung_cell_cropped-hero-150x84.jpg 150w" sizes="(max-width: 620px) 100vw, 620px" data-attachment-id="18781" data-permalink="https://news.cancerresearchuk.org/2020/09/11/targeted-drug-for-lung-cancer-approved-for-nhs-use-in-england/lung_cell_cropped-hero/"...

Touching a nerve: How neuroscience could advance our understanding of cancer

KTSDESIGN/SCIENCE PHOTO LIBRARY When supporters donate to our work, their combined generosity might lead to a new discovery that inches us closer to, for example,...

Nivolumab Demonstrates Clinical Benefits in a Statistically Evaluable Number of Patients with CUP

An investigator-initiated phase II study is the first to show that nivolumab has clinical activity with manageable toxicity in a statistically evaluable number of...